Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 23:
24. The compound of claim 22, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is C3-C8 cycloalkyl, wherein the C3-C8 cycloalkyl is substituted by 1, 2, 3, 4, or 5 independently selected R2b substituents; and
each R2b is independently halogen, C1-C6 alkyl, OR5, 3- to 12-membered heterocyclyl, C6-C14 aryl, or 5- to 10-membered heteroaryl, wherein each C6-C14 aryl is optionally and independently substituted by 1 or more independently selected R4a substituents.